180 related articles for article (PubMed ID: 37540490)
1. FBXO24 Suppresses Breast Cancer Tumorigenesis by Targeting LSD1 for Ubiquitination.
Dong B; Song X; Wang X; Dai T; Wang J; Yu Z; Deng J; Evers BM; Wu Y
Mol Cancer Res; 2023 Dec; 21(12):1303-1316. PubMed ID: 37540490
[TBL] [Abstract][Full Text] [Related]
2. Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.
Cao C; Vasilatos SN; Bhargava R; Fine JL; Oesterreich S; Davidson NE; Huang Y
Oncogene; 2017 Jan; 36(1):133-145. PubMed ID: 27212032
[TBL] [Abstract][Full Text] [Related]
3. The deubiquitinase USP28 stabilizes LSD1 and confers stem-cell-like traits to breast cancer cells.
Wu Y; Wang Y; Yang XH; Kang T; Zhao Y; Wang C; Evers BM; Zhou BP
Cell Rep; 2013 Oct; 5(1):224-36. PubMed ID: 24075993
[TBL] [Abstract][Full Text] [Related]
4. E3 ligase Trim35 inhibits LSD1 demethylase activity through K63-linked ubiquitination and enhances anti-tumor immunity in NSCLC.
Tang F; Lu C; He X; Lin W; Xie B; Gao X; Peng Y; Yang D; Sun L; Weng L
Cell Rep; 2023 Dec; 42(12):113477. PubMed ID: 37979167
[TBL] [Abstract][Full Text] [Related]
5. LSD1 destabilizes FBXW7 and abrogates FBXW7 functions independent of its demethylase activity.
Lan H; Tan M; Zhang Q; Yang F; Wang S; Li H; Xiong X; Sun Y
Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12311-12320. PubMed ID: 31152129
[TBL] [Abstract][Full Text] [Related]
6. The ubiquitin E3 ligase SCF-FBXO24 recognizes deacetylated nucleoside diphosphate kinase A to enhance its degradation.
Chen W; Xiong S; Li J; Li X; Liu Y; Zou C; Mallampalli RK
Mol Cell Biol; 2015 Mar; 35(6):1001-13. PubMed ID: 25582197
[TBL] [Abstract][Full Text] [Related]
7. Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer.
Liu J; Feng J; Li L; Lin L; Ji J; Lin C; Liu L; Zhang N; Duan D; Li Z; Huang B; Zhang Y; Lu J
EMBO Rep; 2020 Feb; 21(2):e48597. PubMed ID: 31833203
[TBL] [Abstract][Full Text] [Related]
8. SUV39H2 methylates and stabilizes LSD1 by inhibiting polyubiquitination in human cancer cells.
Piao L; Suzuki T; Dohmae N; Nakamura Y; Hamamoto R
Oncotarget; 2015 Jul; 6(19):16939-50. PubMed ID: 26183527
[TBL] [Abstract][Full Text] [Related]
9. The R251Q mutation of LSD1 promotes invasion and migration of luminal breast cancer cells.
Zhang Y; Wu T; Wang Y; Zhao X; Zhao B; Zhao X; Zhang Q; Jin Y; Li Z; Hu X
Int J Biol Macromol; 2020 Dec; 164():4000-4009. PubMed ID: 32882276
[TBL] [Abstract][Full Text] [Related]
10. Histone demethylase LSD2 acts as an E3 ubiquitin ligase and inhibits cancer cell growth through promoting proteasomal degradation of OGT.
Yang Y; Yin X; Yang H; Xu Y
Mol Cell; 2015 Apr; 58(1):47-59. PubMed ID: 25773598
[TBL] [Abstract][Full Text] [Related]
11. OTUD7B Deubiquitinates LSD1 to Govern Its Binding Partner Specificity, Homeostasis, and Breast Cancer Metastasis.
Gong Z; Li A; Ding J; Li Q; Zhang L; Li Y; Meng Z; Chen F; Huang J; Zhou D; Hu R; Ye J; Liu W; You H
Adv Sci (Weinh); 2021 Aug; 8(15):e2004504. PubMed ID: 34050636
[TBL] [Abstract][Full Text] [Related]
12. The histone demethylase LSD1/KDM1A promotes the DNA damage response.
Mosammaparast N; Kim H; Laurent B; Zhao Y; Lim HJ; Majid MC; Dango S; Luo Y; Hempel K; Sowa ME; Gygi SP; Steen H; Harper JW; Yankner B; Shi Y
J Cell Biol; 2013 Nov; 203(3):457-70. PubMed ID: 24217620
[TBL] [Abstract][Full Text] [Related]
13. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.
Guo Y; Li Q; Zhao G; Zhang J; Yuan H; Feng T; Ou D; Gu R; Li S; Li K; Lin P
Cell Death Dis; 2021 Oct; 12(10):945. PubMed ID: 34650049
[TBL] [Abstract][Full Text] [Related]
14. HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells.
Cao C; Wu H; Vasilatos SN; Chandran U; Qin Y; Wan Y; Oesterreich S; Davidson NE; Huang Y
Int J Cancer; 2018 Sep; 143(6):1388-1401. PubMed ID: 29633255
[TBL] [Abstract][Full Text] [Related]
15. Biological roles of LSD1 beyond its demethylase activity.
Gu F; Lin Y; Wang Z; Wu X; Ye Z; Wang Y; Lan H
Cell Mol Life Sci; 2020 Sep; 77(17):3341-3350. PubMed ID: 32193608
[TBL] [Abstract][Full Text] [Related]
16. LSD1 demethylates HIF1α to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis.
Lee JY; Park JH; Choi HJ; Won HY; Joo HS; Shin DH; Park MK; Han B; Kim KP; Lee TJ; Croce CM; Kong G
Oncogene; 2017 Sep; 36(39):5512-5521. PubMed ID: 28534506
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells.
Vasilatos SN; Katz TA; Oesterreich S; Wan Y; Davidson NE; Huang Y
Carcinogenesis; 2013 Jun; 34(6):1196-207. PubMed ID: 23354309
[TBL] [Abstract][Full Text] [Related]
18. ERRα protein is stabilized by LSD1 in a demethylation-independent manner.
Carnesecchi J; Cerutti C; Vanacker JM; Forcet C
PLoS One; 2017; 12(11):e0188871. PubMed ID: 29190800
[TBL] [Abstract][Full Text] [Related]
19. Modulation of LSD1 phosphorylation by CK2/WIP1 regulates RNF168-dependent 53BP1 recruitment in response to DNA damage.
Peng B; Wang J; Hu Y; Zhao H; Hou W; Zhao H; Wang H; Liao J; Xu X
Nucleic Acids Res; 2015 Jul; 43(12):5936-47. PubMed ID: 25999347
[TBL] [Abstract][Full Text] [Related]
20. LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.
He Y; Zhao Y; Wang L; Bohrer LR; Pan Y; Wang L; Huang H
Oncogene; 2018 Jan; 37(4):534-543. PubMed ID: 28991226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
